Recalcitrant pyoderma gangrenosum: Treatment with thalidomide

This publication has 10 references indexed in Scilit:

• Guideline for the clinical use and dispensing of thalidomide
  Published by Oxford University Press (OUP) ,1994
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
  The Journal of Experimental Medicine, 1993
• Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.
  The Journal of Experimental Medicine, 1991
• Pyoderma gangrenosum associated with Behçet's disease: Treatment with thalidomide
  Journal of the American Academy of Dermatology, 1990
• 4 Thalidomide and Congeners as Anti-inflammatory Agents
  Progress in Medicinal Chemistry, 1985
• Thalidomide: Use and possible mode of action in reactional lepromatous leprosy and in various other conditions
  Journal of the American Academy of Dermatology, 1982
• Inhibition of PMN leukocytes chemotaxis by thalidomide
  Archives of Dermatological Research, 1980
• Prolongation of Skin Homograft Survival by Thalidomide
  BMJ, 1965
• Thalidomide in the treatment of lepra reactions
  Clinical Pharmacology & Therapeutics, 1965
• The Saga of Thalidomide
  New England Journal of Medicine, 1962